For Bourla, the implication is evident: The U.S. may be overly concentrated on impeding China's progress rather than accelerating its own. This perspective is influencing Pfizer's approach. Bourla mentioned the firm now regards China not merely as a pharmaceutical market but progressively as an innovation origin. Simultaneously, the 64-year-old cautioned that American policymakers and corporate heads must recalibrate their focus.
Telemetry on Home/ProOct 2021Never-
，详情可参考金山文档
Follow one of the specific commands below, according to your use-case:
当然，实际表现有待后续验证，但基于梅赛德斯-奔驰与 Momenta 目前的合作成果，这套系统值得期待。